ECG vs IESC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 18, 2026

ECG

38.4
AI Score
VS
ECG Wins

IESC

32.2
AI Score

Investment Advisor Scores

ECG

38score
Recommendation
EXTENDED

IESC

32score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric ECG IESC Winner
Forward P/E 30.1205 208.3333 ECG
PEG Ratio 0 0 Tie
Revenue Growth 33.7% 39.6% IESC
Earnings Growth 59.2% 98.7% IESC
Tradestie Score 38.4/100 32.2/100 ECG
Profit Margin 6.0% 11.4% IESC
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED EXTENDED Tie

Relative Price Performance (Last 90 Days)

ECG 1M: -8.7% · 3M: -16.4% IESC 1M: +3.2% · 3M: +5.7%

Current Technical Phase

ECG

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.2%), weak momentum, RSI 42

RSI (14): 42.5 · Price: $125.96

IESC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.0 · Price: $685.04

Fundamentals Snapshot

Metric ECG IESC
Market Cap
Forward P/E 21.0 27.3
Trailing P/E 26.1 31.0
Revenue (TTM)
Revenue Growth 0.3% 0.4%
Gross Margin 0.1% 0.3%
Operating Margin 0.1% 0.1%
EPS 4.81 22.06
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ECG is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.